Background: Clear diagnosis of bladder outlet obstruction with prostatic hyperplasia between January 2004 and December 2014, a total of 990 urethral stents were placed in 762 patients without surgery for various reasons. We made a return visit. The average age of the patients was 83 years old. There were 531 cases of heart and brain diseases, 97 cases of pulmonary diseases, 99 cases of diabetes complications and 35 cases of advanced malignant tumors. Among them, 92 cases with cystostomy. Methods: The patient lay flat on the DSA examination table and was routinely disinfected. A mixture of 75% meglumine diatrizoate and 2% lidocaine was injected through the urethral orifice. The images were collected by retrograde urography and the urethral mucosal anaesthesia was performed at the same time. After measuring the length of the prostate urethra, we choose the suitable urethral stents. Generally, we use the straight tube type braided reticular memory alloy stent. With obvious asymmetry of the internal urethral orifice patients, the backrest or two urethral stents should be used. Put the stent into prostate through X-ray monitoring. The best upper end of the stent is about ±0.5 centimeter in the internal urethra orifice
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